New communication on Mablink by Puls@lys
After having earned the #FrenchTechSeed label in the middle of March, Puls@lys has made an exclusive communication on our Antibody-Drug linker technology as a breakthrough innovation as well as its …
Mablink has been awarded the R2B Onco 2019 Trophy
With more than 700 participants last April 4th/5th, the Auvergne-Rhône-Alpes Cancer Research Forum is one of the most federating events. During this event took place the Research2Business (R2B) Oncology Meeting …
Mablink earned the French Tech Seed Label
French Tech Seed labeled company. Our company has recently been granted with the French Tech Seed label which rewards DeepTech projects lead by young dynamic companies. Our highly potent technology …